top of page
MAGELLAN
BIOANALYTICS
Biotech & Pharma
Magellan Bioanalytics Software Technology
Explore why we believe our technology increases likelihood of success in classifying patients
Magellan has developed an AI software that is capable of matching the data output of today's mass spectrometers, allowing true OMICS analysis of the proteome, lipidome, and metabolome. In addition, our software can integrate this data with other data types, such as sequencing. Both of these innovations mark unprecedented leaps forward in potential ability to segment patients for trials, treatment, and patent extension purposes.
Contact us to learn how Magellan's
new technology could help your drug program
(c) 2018 to 2025
bottom of page